Suppr超能文献

根据日本标准卒中登记研究对蛛网膜下腔出血的分析——发病率、转归及与国际蛛网膜下腔动脉瘤试验的比较

Analysis of subarachnoid hemorrhage according to the Japanese Standard Stroke Registry Study--incidence, outcome, and comparison with the International Subarachnoid Aneurysm Trial.

作者信息

Ikawa Fusao, Ohbayashi Naohiko, Imada Yasutaka, Matsushige Toshinori, Kajihara Yosuke, Inagawa Tetsuji, Kobayashi Shotai

机构信息

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Shimane, Japan.

出版信息

Neurol Med Chir (Tokyo). 2004 May;44(5):275-6. doi: 10.2176/nmc.44.275.

Abstract

The data for subarachnoid hemorrhage (SAH) from the Japanese Standard Stroke Registry Study (JSSRS) were analyzed to evaluate the incidence of SAH according to age, neurological grading and outcome, and outcome of surgical clipping, for comparison with the International Subarachnoid Aneurysm Trial (ISAT). From the ISSRS data, the peak incidence of SAH was the sixth decade in males and the eighth decade in females. The overall mortality was 22%, and good outcome, better than 2 on the modified Rankin Scale (mRS), at discharge was achieved in 58% of cases. Radical treatment was performed in 62.6% of all SAH cases, 58.7% with surgical clipping and 3.2% with endovascular coiling. Poor outcome, worse than 3 on the mRS, occurred in 26.6% of patients under 60 years, 47.3% between 60-69 years, 54.2% between 70-79 years, and 72.9% 80 years or over. From the ISAT data, 88% of patients were in grades 1-2 of the World Federation of Neurological Surgeons (WFNS) grading system in both surgical clipping and endovascular coiling groups, 94% in grades 1-3, and 98% in grades 1-4. Poor outcome, worse than 3 on the mRS, at 2 months occurred in 25.4% and 36.4% of patients with endovascular coiling and surgical clipping, respectively. Limiting the patients in the JSSRS to WFNS grades 1-2 showed poor outcome, worse than 3 on the mRS, occurred in 12.8%, and in grades 1-3 and 1-4 occurred in only 16.3% and 23.0%, respectively.

摘要

分析了来自日本标准卒中登记研究(JSSRS)的蛛网膜下腔出血(SAH)数据,以评估SAH的发病率(根据年龄、神经功能分级和预后)以及手术夹闭的预后情况,以便与国际蛛网膜下腔动脉瘤试验(ISAT)进行比较。根据JSSRS数据,SAH的发病率高峰在男性为第六个十年,在女性为第八个十年。总体死亡率为22%,58%的病例在出院时获得了良好预后(改良Rankin量表[mRS]评分优于2分)。在所有SAH病例中,62.6%进行了根治性治疗,其中58.7%采用手术夹闭,3.2%采用血管内栓塞。mRS评分大于3分的不良预后在60岁以下患者中占26.6%,60 - 69岁患者中占47.3%,70 - 79岁患者中占54.2%,80岁及以上患者中占72.9%。根据ISAT数据,在手术夹闭组和血管内栓塞组中,88%的患者属于世界神经外科医师联合会(WFNS)分级系统的1 - 2级,94%属于1 - 3级,98%属于1 - 4级。血管内栓塞组和手术夹闭组中,mRS评分大于3分的不良预后在2个月时分别占25.4%和36.4%。将JSSRS中的患者限制为WFNS 1 - 2级时,mRS评分大于3分的不良预后占12.8%,1 - 3级和1 - 4级分别仅占16.3%和23.0%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验